PERSPECTA

News from every angle

← Back to headlines

Eli Lilly Stock Performance After New Drug Approval

Investors are evaluating whether Eli Lilly's stock is a good buy following a recent brand new drug approval.

7 Apr, 16:06 — 7 Apr, 16:06
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual23h ago

Is Eli Lilly Stock a Buy After a Brand New Approval?

Read full article →

Related Stories

Philippine Lawmaker Proposes VAT Cut Amid Fuel Crisis

10m ago

NNPC Exports New Cawthorne Crude Grade to Netherlands

11m ago

Moroccan-Born Trader Hamza Lemssouguer Builds $20 Billion Hedge Fund

14m ago

Ana Mitreska and Igor Velichkovski Appointed Vice Governors of National Bank

21m ago